SCHEMBL23701095

SCHEMBL23701095

COc1ccc(C(=O)Nc2ccc3c(c2)CN(C(=O)c2ccc(OC)nc2)CC3)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.56
TMPRSS2 O15393 3/20 0.54
RAB9A P51151 2/20 0.54
KMT2A Q03164 1/20 0.54
PRKAA2 P54646 2/20 0.47
KDM4E B2RXH2 2/20 0.47
USP2 O75604 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
NAMPT P43490 1/20 0.46
SYK P43405 1/20 0.44
P4HTM Q9NXG6 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30014687 1.00 NPC1 (0.56) NPC1TMPRSS2RAB9AKMT2APRKAA2
SCHEMBL31553210 0.93 NPC1 (0.50) NPC1TMPRSS2RAB9AKMT2APRKAA2
SCHEMBL23561729 0.85 CA1 (0.58) NPC1RAB9AKMT2AALDH1A1MAPT
SCHEMBL30014874 0.84 AURKA (0.46) NPC1TMPRSS2RAB9AKDM4EUSP2
SCHEMBL23538224 0.84 AURKA (0.46) NPC1TMPRSS2RAB9AKDM4EUSP2
SCHEMBL23562075 0.82 CA1 (0.42) NPC1KMT2AMAPTCA1CA2
SCHEMBL30014963 0.82 CA1 (0.42) NPC1KMT2AMAPTCA1CA2
SCHEMBL23562072 0.82 GPR183 (0.48) MAPTCA1CA2CA7CA9
SCHEMBL23701350 0.81 CA1 (0.48) KMT2AMAPTCA1CA2CA7
SCHEMBL30014279 0.81 CA1 (0.48) KMT2AMAPTCA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4077306-B1 COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION INC (US) 2025-05-07 EP disclosed
US-11992535-B2 Compounds and probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2024-05-28 US disclosed
US-20210236663-A1 COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2021-08-05 US disclosed
US-20210236663-A1 COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210236663-A1 COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 NPC1 297/4885TMPRSS2 4240/4885RAB9A 1365/4885
US-11992535-B2 Compounds and probes for imaging huntingtin protein HTT, HYPK, HSPBP1 NPC1 297/4885TMPRSS2 4240/4885RAB9A 1365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.